Automate Your Wheel Strategy on BIAFW
With Tiblio's Option Bot, you can configure your own wheel strategy including BIAFW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BIAFW
- Rev/Share 0.5419
- Book/Share 0.0885
- PB 2.8361
- Debt/Equity 0.9248
- CurrentRatio 0.5457
- ROIC -3.4754
- MktCap 7146191.0
- FreeCF/Share -0.409
- PFCF -1.0748
- PE -0.4192
- Debt/Assets 0.24
- DivYield 0
- ROE -3.6764
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About bioAffinity Technologies, Inc. (BIAFW)
- IPO Date
- Website http://www.bioaffinitytech.com
- Industry Medical - Diagnostics & Research
- CEO Ms. Maria Zannes J.D.
- Employees 57
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.